Arrhythmia Research Technology (HRT) Posts Surprise Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Net income (loss) per share – basic: -0.02
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Net income (loss) per share – basic: -0.02
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q3 EPS of ($0.10), $0.60 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $5.23 million versus the consensus estimate of $136.4 million.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Intel shares fall as competitor reports record results
- Qualcomm stock climbs after SpaceX 5G network deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
